Understanding ovarian cancer starts with real stories. In this episode of Teal Talk, the official podcast from the National Ovarian Cancer Coalition (NOCC), we sit down with Evelyn, a mother and ovarian cancer survivor, to explore her powerful story of diagnosis, resilience, and the role of biomarker testing in shaping her treatment plan.

Learn how biomarkers, including HRD (homologous recombination deficiency), can guide personalized treatment approaches such as PARP inhibitors, and why patient education and self-advocacy are essential in the ovarian cancer journey. Evelyn’s candid reflections on recognizing symptoms, navigating emotions, and managing care offer hope and clarity for anyone impacted by ovarian cancer.

💬 Like, comment, and subscribe for more vital discussions about ovarian cancer. 📋 Survey Link: https://bit.ly/tealtalksurvey 👉 For more information about ovarian cancer and the National Ovarian Cancer Coalition, visit ovarian.org.

This podcast is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always talk to a qualified healthcare provider if you have questions about your health. The podcast is created independently by the National Ovarian Cancer Coalition and is not influenced by sponsors or outside groups.